LifeScan Brand Guidelines: OneTouch, J&J, Platinum Equity & a 2025 Restructuring

From a Johnson & Johnson unit to a standalone company.

LifeScan makes blood-glucose meters, test strips and lancets under the OneTouch brand. English Wikipedia says the company was established in 1981 and acquired by Johnson & Johnson in 1986, and that it later became the central part of J&J’s diabetes device business. Its headquarters are now in Malvern, Pennsylvania, and the company says it has worked in glucose management “for more than 40 years.”

Wikipedia credits the OneTouch systems with changing home glucose testing. At first, it says, the measurement used a test strip that changed colour according to the glucose in a blood sample, and LifeScan became the world’s leading producer of such systems in the early 1990s; the measurement technology later moved to electrochemistry. The product families it names are OneTouch Ultra and OneTouch Verio. Wikipedia also notes that Animas, the West Chester insulin-pump maker J&J bought in 2006 and later closed, reported to LifeScan.

J&J announced in 2017 that it would leave the diabetes-device market, according to Wikipedia, and in June 2018 agreed to sell LifeScan to the investment firm Platinum Equity. Platinum Equity announced on 1 October 2018 that the acquisition had been completed, apart from some non-US jurisdictions expected to close later. At that point it gave LifeScan’s headquarters as Chesterbrook, Pennsylvania, and Zug, Switzerland, and said the company served about 20 million patients in more than 90 countries. Platinum Equity described LifeScan as a leader in diabetes care for more than 30 years, and listed the OneTouch portfolio as personal blood-glucose meters, testing strips, lancets, point-of-care testing systems and integrated digital solutions.

Meters, strips and a planned CGM.

LifeScan’s corporate site describes a range that runs from OneTouch meters, test strips and lancets to an integrated digital health platform and hospital point-of-care systems. The company says more than 20 million people around the world use its OneTouch products, and its corporate site links to a separate OneTouch website.

On manufacturing, English Wikipedia says LifeScan has facilities in Inverness, Scotland, and Cabo Rojo, Puerto Rico. In 2024 the company said its LifeScan Graduate Programme had been named in the Princess Royal Training Awards class of 2024, which it describes as celebrating organisations’ commitment to learning and development.

In February 2026 LifeScan announced a partnership with the biosensor company i-SENS to launch a continuous glucose monitoring system under the name OneTouch Vita. LifeScan said the two companies expected to launch the CGM products in Germany, Ireland, Portugal and Belgium by early 2027, with more markets to follow; at the time of the announcement this was a plan rather than a launch. LifeScan said the partnership would combine its OneTouch brand and global distribution network with i-SENS’s technology and manufacturing capacity, and added that there were no changes to the rest of the OneTouch portfolio.

Figures for the company’s size come from different years. Wikipedia says LifeScan employed about 2,400 people in early 2018; at the time of the 2025 filing, the company spoke of serving more than 20 million customers in more than 50 countries, against the more than 90 countries Platinum Equity cited in 2018.

How diabetes device makers present themselves.

Diabetes device makers sell small things that people wear, carry or use many times a day: continuous glucose monitors worn on the upper arm or the belly, insulin pumps and tubeless patch pumps, blood-glucose meters with their test strips, and the pen needles and syringes used for injections. Their brand worlds are built around those objects, and increasingly around the data the objects produce.

A typical presentation pairs a close-up of a sensor or pump on skin with a phone screen showing a glucose graph and trend arrows. Apps and watch faces have become as central as the hardware: sensor makers describe readings sent wirelessly to phones, shared with family members and passed to insulin pumps, and that connection between devices is often the story the brand tells.

Photography in the category tends to be bright and active, with runners, swimmers, parents and children, while meter-and-strip brands lean on clean packshots of the meter, the strip pot and the lancing device. Regulation shapes the words as much as the pictures: product names come with indications, approval dates and age ranges, and marketing copy stays within what regulators such as the U.S. Food and Drug Administration have cleared.

The industry meets at medical congresses such as the American Diabetes Association’s Scientific Sessions, the annual meeting of the European Association for the Study of Diabetes (EASD) and the ATTD conference on advanced technologies and treatments for diabetes, where new devices and study results are presented to clinicians. This guide sets out what can be checked about each maker — who founded it, who owns it, where it says its products are made and what regulators have said — and marks clearly what rests only on the company’s own word.

A new logo in 2018, new owners in 2025.

Under Platinum Equity, LifeScan gave itself a look of its own. On the day the sale was completed, Platinum Equity said LifeScan had unveiled a new corporate logo and brand identity, while its core consumer brands stayed unchanged. The corporate site still presents OneTouch as the product brand and LifeScan as the company behind it.

The ownership changed again in 2025. On 15 July 2025 LifeScan said it had signed a restructuring support agreement with its lenders and with Platinum Equity and had filed prearranged Chapter 11 cases in the US Bankruptcy Court for the Southern District of Texas. Its international subsidiaries were not part of the filing, and the company said it would keep operating in the ordinary course and expected to cut more than 75% of its debt. The court approved its plan of reorganisation on 27 October 2025, and on 8 December 2025 LifeScan announced that it had emerged from the process, now owned by a group of its existing lenders including Canyon Partners and Brigade Capital Management. English Wikipedia says the business now operates as LifeScan Enterprises LLC, the name that also appears on the company’s website.

The company states its vision as “a world without limits for people with diabetes,” and lists four shared values: Care, Create, Connect and Compete. It describes its products as “defined by simplicity, accuracy and trust,” and its website includes a section for the LifeScan Diabetes Institute. In announcing the 2025 restructuring, the chief executive said the company would keep working to expand access to OneTouch in the US without the need for a prescription; on leaving Chapter 11, LifeScan said its new owners would support plans to improve product affordability and accessibility in key markets.

For a design guide, LifeScan shows a company name kept separate from its product brand, with a corporate identity redrawn when the business left J&J. Compare Abbott, another maker of glucose-monitoring products, and i-SENS, its CGM partner. For this guide we use a deep blue, a mid blue and a warm coral with a sans, an unofficial interpretation; no product or logo is reproduced.

Keep LifeScan’s identity on hand — save it to a board in the Made Good inspiration library.